Transdermal fentanyl recall - Alvogen product

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jgold@ismp.org. 

1 post / 0 new
Log in or register to post comments
Tue, 04/23/2019 - 07:52
#1
Mike Cohen
Mike Cohen's picture
Offline
Last seen: 2 months 4 days ago
Joined: 06/08/2014 - 19:54
Transdermal fentanyl recall - Alvogen product

In case anyone missed the FDA alert yesterday, we thought it was imp0ortant enough to repeat here for anyone using Alvogen transdermal fentanyl.

Patients on low dose 12 mcg/hr patch might be at risk due to product mislabeling.

A small number of cartons labeled 12 mcg/h Fentanyl Transdermal System patches contained 50 mcg/h patches. The 50 mcg/h patches that were included in cartons labeled 12 mcg/h are individually labeled as 50 mcg/h. However, patients may miss identifying the strength on the individual patch, which obviously could be life threatening, especially for first time users.

Affected lots include:
Lot 180060 of Fentanyl Transdermal System, 12 mcg/h, expiration date 05/2020
Lot 180073 of Fentanyl Transdermal System, 12 mcg/h, expiration date 06/2020

Mike

Top